Nordstrom, Ethan Allen & extra
Pedestrians pass outside a Nordstrom Inc. store in the Midtown neighborhood of New York on March 20, 2020.
Gabby Jones | Bloomberg | Getty Images
Check out the companies making headlines after Wednesday’s bell:
Nordstrom – The retailer’s inventory dropped more than 3% after the retailer reported that sales during the holiday seasons fell 22% year over year. Despite the decline, CEO Erik Nordstrom said the company is picking up momentum after the holiday season “as we continue to break new ground to better serve customers on their terms with greater convenience and connection.”
Ethan Allen – The furniture company’s shares rose 4.8% on a better-than-expected earnings forecast for the second fiscal quarter. Ethan Allen predicts earnings per share will be between 67 cents per share and 69 cents per share, beating a FactSet estimate of 46 cents per share. “Despite many challenges due to the ongoing COVID-19 pandemic, we had a strong performance,” CEO Farooq Kathwari said in a statement.
Organogenesis – The medical company’s shares rose more than 25%. Organogenesis reported preliminary sales for 2020 that exceeded estimates. The company announced that full-year 2020 revenue ranged from $ 336.1 million to $ 337.5 million. Analysts expect sales of 312.3 million US dollars.